Original Articles
Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap
Tu X, Kim RY, Brown AC, de Jong E, Jones-Freeman B, Ali MK, Gomez HM, Budden KF, Starkey MR, Cameron GJM, Loering S, Nguyen DH, Nair PM, Haw TJ, Alemao CA, Faiz A, Tay HL, Wark PAB, Knight DA, Foster PS, Bosco A, Horvat JC, Hansbro PM, Donovan C.
J Allergy Clin Immunol, S0091-6749(22), 2022, pp. 00706-0
Differences in pulmonary group 2 innate lymphoid cells are dependent on mouse age, sex and strain
Loering S, Cameron GJM, Bhatt NP, Belz GT, Foster PS, Hansbro PM, Starkey MR.
Immunol Cell Biol, vol. 99(5), 2020, pp. 542-551
Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury
Cameron GJM, Cautivo KM, Loering S, Jiang SH, Deshpande AV, Foster PS, McKenzie ANJ, Molofsky AB, Hansbro PM, Starkey MR.
Front Immunol, vol. 10(1), 2019, p. 826
Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease
Donovan C, Starkey MR, Kim RY, Rana BMJ, Barlow JL, Jones B, Haw TJ, Mono Nair P, Budden K, Cameron GJM, Horvat JC, Wark PAB, Foster PS, McKenzie ANJ, Hansbro PM.
J Leukoc Biol, vol. 105(1), 2019, pp. 143-150
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis
Starkey MR, Plank MW, Casolari P, Papi A, Pavlidis S, Guo Y, Cameron GJM, Haw TJ, Tam A, Obiedat M, Donovan C, Hansbro NG, Nguyen DH, Nair PM, Kim RY, Horvat JC, Kaiko GE, Durum SK, Wark PAB, Sin DD, Caramori G, Adcock IM, Foster PS, Hansbro PM.
Eur Respir J, vol. 54(1), 2019, p. 1800174
Reviews
Emerging therapeutic potential of group 2 innate lymphoid cells in acute kidney injury
Cameron GJM, Jiang SH, Loering S, Deshpande AV, Hansbro PM, Starkey MR.
J Pathol, vol. 248(1), 2019, pp. 9-15
Lung development and emerging roles for type 2 immunity
Loering S, Cameron GJM, Starkey MR, Hansbro PM.
J Pathol, vol. 247(5), 2019, pp. 686-696